“Decreased ZMIZ1 Inhibits Melanin Production In Vitro, Potential Therapeutic Target For Vitiligo”

https://pubmed.ncbi.nlm.nih.gov/38117454

The study finds that decreased ZMIZ1, associated with vitiligo, inhibits melanin production in vitro by regulating mTOR/AKT/GSK-3β-mediated glucose uptake, suggesting a potential therapeutic target.